Skip to main content
TipRanks
Go Ultimate75% OFF

Aridis Pharmaceuticals (ARDS) Q3 2023 Earnings Report

203 Followers

ARDS Q3 2023 EPS Results

Actual EPS
$0.00
Consensus EPS
-$0.10
Beat/Miss
Beat by +$0.10
One Year Ago EPS
-$0.47

ARDS Q3 2023 Revenue Results

Actual Revenue
$417.00K
Expected Revenue
$1.50M
Beat/Miss
Missed by -$1.08M
YoY Revenue Growth
+4.51%

Earnings Announcement Details

Quarter
Q3 2023
Date
11/03/2023
Time
After Close
Conference Call
Friday, November 3, 2023

Q3 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

ARDS Earnings History

ARDS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 20, 20252025 (Q1)―-――
Nov 20, 20242024 (Q3)―-0―
Aug 13, 20242024 (Q2)―-0.33―
May 14, 20242024 (Q1)―-――
Nov 03, 20232023 (Q3)-0.100.00-0.47100.00% (+0.47)
Aug 15, 20232023 (Q2)―-――
Jun 08, 20232023 (Q1)―-0.22-0.4450.00% (+0.22)
Mar 30, 20232022 (Q4)-0.41-0.40-0.9256.52% (+0.52)
Nov 21, 20222022 (Q3)-0.17-0.47-1.9475.77% (+1.47)
Aug 16, 20222022 (Q2)-0.06-0.45-0.498.16% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed